MENU
Seres Therapeutics (MCRB) Ownership - Who owns Seres Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
145.36M
P/E Ratio
N/A
Total Cash
71.23M
Projected Growth
N/A
Total Debt
212.63M
Revenue
374K
Risk (Beta)
-0.12
Dividend Yield
N/A
Total Cash/Share
0.47
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
MCRB
Capitalization
145M
P/E Ratio
N/A
Risk (Beta)
-0.12
Dividend Yield
N/A
Total Cash
71.2M
Total Cash/Share
0.47
Total Debt
213M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
374K
ROE
N/A
Book Value
-87.07M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
152K
Current Ratio
1.38
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-139.66M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.53
Shares Held By Institutions
79.1M
Shares Outstanding - Current
152M
Total Liabilities
409M
Total Volume MTD
N/A
Value
-1
Gain YTD
-35.714
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
101 Cambridgepark Drive
Phone
+1 617 945-9626
Employees
233
Web
https://www.serestherapeutics.com